Ann: Compelling results for 2591 dose ranging study in PMS model, page-28

Hi Was,

The selling now is very clear why. Every market in the world is selling due to covid 19.yes some more than others, but that is due to the risk involved. I even considered selling and re entering to get a lower position. So no doubt other are doing/thinking the same.

1 question I do have is. If Acadia draws out the process, will they learn more and more each day on current results from already enrolled patients? Basically is it in their best interest to drag out the ROW deal until they can learn as much as they can before agreeing to (hopefully) Neuren's huge offer.